ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027

Market By Age Group, Education, Drugs & Devices, End Users And Geography | Forecasts 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per the research conducted by Triton, the Asia-Pacific contraceptive market is expected to reach at a CAGR of 7.70% during the forecast period 2019-2027.

The countries covered in this region are:

O         China

O         New Zealand

O         Japan

O         Australia

O         India

O         South Korea

O         ASEAN countries

O         rest of APAC

The research report contains necessary information about the market definition, Pestel’s outlook, key insights, Porter's five force analysis, market attractiveness index and the regulatory outlook.

The countries in the Asia-Pacific regions, especially the developing ones such as China and India, have been grappling with issues such as overpopulation. Thus, to keep population growth under check, the national governments have come up with initiatives to spread awareness about the importance of family planning and birth control. The contraceptive market is being driven by the easy availability of OTC oral contraceptive pills. The rising incidences of STIs have made individuals cautious and have thus led to many of them adopting contraceptive techniques as a preventive measure.

In spite of all these advantages offered by them, factors such as lack of acceptance faced by contraceptives are impeding the market growth. Socio-cultural opposition for the use of contraceptives in countries having conservative populations is a major restraining factor. Moreover, lack of accessibility and misperceptions about the use of contraceptives are some of the challenges faced by the contraceptive industry.

The Asia-Pacific contraceptive market has been segregated into various categories based on age groups, education, drugs & devices and end users. Companies such as Cooper Surgical, Inc., Merck & Co., Inc., Church & Dwight Co., Inc.,    Teva Pharmaceutical Industries, Ltd., Apothecus Pharmaceutical Corporation, Pregna, Pfizer, Inc., Bayer AG, Melbea, SMB Corporation, Reckitt Benckiser PLC, Mayer Laboratories, Inc., Ocon Medical, Ltd., Okamoto Industries, Inc., Afaxys, Inc., Allergan, Inc. and Agile Therapeutics have been the leading manufacturers of contraceptives.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    CONTRACEPTIVE MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. PESTEL OUTLOOK

2.5. MARKET ATTRACTIVENESS INDEX

2.6. MARKET PLAYER POSITIONING

2.7. KEY INSIGHTS

2.7.1.   ORAL CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS

2.7.2.   CONDOMS ARE THE WIDELY USED CONTRACEPTIVES DEVICE

2.7.3.   AGE GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE ASIA-PACIFIC CONTRACEPTIVE MARKET

2.8. MARKET DRIVERS

2.8.1.   GROWING COGNIZANCE FOR CONTRACEPTIVES

2.8.2.   INCREASING USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY

2.8.3.   SURGE IN THE INITIATIVES OF GOVERNMENT AND NGO

2.8.4.   GROWING AWARENESS ABOUT STD

2.9. MARKET RESTRAINTS

2.9.1.   SIDE EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES

2.9.2.   LIMITED ACCESS TO CONTRACEPTIVES

2.10.            MARKET OPPORTUNITIES

2.10.1.                RISING DISPOSABLE INCOME IN EMERGING ECONOMIES

2.10.2.                UNMET MEDICAL NEEDS IN THE EMERGING ECONOMIES

2.10.3.                TECHNOLOGICAL ADVANCEMENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF ACCEPTANCE OF SOCIETY

3.    CONTRACEPTIVE MARKET OUTLOOK - BY EDUCATION

3.1. LESS THAN HIGH SCHOOL

3.2. HIGH SCHOOL GRADUATE

3.3. COLLEGE GRADUATE

3.4. OTHER COLLEGE DEGREES

4.    CONTRACEPTIVE MARKET OUTLOOK - BY AGE GROUP

4.1. 15–24 YEARS

4.2. 25–34 YEARS

4.3. 35–44 YEARS

4.4. ABOVE 44 YEARS

5.    CONTRACEPTIVE MARKET OUTLOOK - BY END USER

5.1. HOUSEHOLDS

5.2. CLINICS

5.3. HOSPITALS

6.    CONTRACEPTIVE MARKET OUTLOOK - BY DRUGS AND DEVICES

6.1. CONTRACEPTIVES DRUGS

6.1.1.   ORAL CONTRACEPTIVE PILLS

6.1.2.   INJECTABLE CONTRACEPTIVES

6.1.3.   TOPICAL CONTRACEPTIVES

6.2. CONTRACEPTIVE DEVICES

6.2.1.   MALE CONDOMS

6.2.2.   FEMALE CONDOMS

6.2.3.   DIAPHRAGMS

6.2.4.   CONTRACEPTIVE SPONGES

6.2.5.   VAGINAL RINGS

6.2.6.   SUBDERMAL IMPLANTS

6.2.7.   INTRA-UTERINE DEVICES

6.2.7.1.      COPPER INTRA-UTERINE DEVICES

6.2.7.2.      HORMONAL INTRA-UTERINE DEVICES

7.    CONTRACEPTIVE MARKET - REGIONAL OUTLOOK

7.1. ASIA-PACIFIC

7.1.1.   COUNTRY ANALYSIS

7.1.1.1.      JAPAN

7.1.1.2.      CHINA

7.1.1.3.      INDIA

7.1.1.4.      AUSTRALIA & NEW ZEALAND

7.1.1.5.      SOUTH KOREA

7.1.1.6.      ASEAN COUNTRIES

7.1.1.7.      REST OF ASIA-PACIFIC

8.    COMPETITIVE LANDSCAPE

8.1. COMPANY PROFILES

8.1.1.   ALLERGAN INC.

8.1.2.   BAYER AG

8.1.3.   MELBEA

8.1.4.   PREGNA

8.1.5.   PFIZER, INC.

8.1.6.   CHURCH & DWIGHT CO., INC.

8.1.7.   AFAXYS, INC.

8.1.8.   APOTHECUS PHARMACEUTICAL CORPORATION

8.1.9.   COOPER SURGICAL INC

8.1.10.                OKAMOTO INDUSTRIES, INC

8.1.11.                MAYER LABORATORIES, INC.

8.1.12.                AGILE THERAPEUTICS

8.1.13.                MERCK & CO., INC.

8.1.14.                RECKITT BENCKISER PLC

8.1.15.                SMB CORPORATION

8.1.16.                TEVA PHARMACEUTICAL INDUSTRIES LTD.

8.1.17.                OCON MEDICAL LTD

9.    METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of table

TABLE 1        ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

TABLE 2        CONTRACEPTIVE   MARKET PLAYER POSITIONING OUTLOOK 2017

TABLE 3        ASIA-PACIFIC CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 4        ASIA-PACIFIC CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 5        ASIA-PACIFIC CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 6        ASIA-PACIFIC CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 7        ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET 2019-2027 ($ MILLION)

TABLE 9        ASIA-PACIFIC INJECTABLE CONTRACEPTIVESMARKET 2019-2027 ($ MILLION)

TABLE 10      ASIA-PACIFIC TOPICAL CONTRACEPTIVESMARKET 2019-2027 ($ MILLION)

TABLE 11      ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 12      ASIA-PACIFIC INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 13      ASIA-PACIFIC CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 2      PORTER’S FIVE FORCE MODEL

FIGURE 3      ASIA-PACIFIC CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

FIGURE 4      ASIA-PACIFIC CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

FIGURE 5      ASIA-PACIFIC CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

FIGURE 6      ASIA-PACIFIC CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

FIGURE 7      ASIA-PACIFIC CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

FIGURE 8      ASIA-PACIFIC CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

FIGURE 9      ASIA-PACIFIC CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

FIGURE 10   ASIA-PACIFIC CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

FIGURE 11   ASIA-PACIFIC CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

FIGURE 12   ASIA-PACIFIC CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

FIGURE 13   ASIA-PACIFIC CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 14   ASIA-PACIFIC CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

FIGURE 15   ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

FIGURE 16   ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 17   ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 18   ASIA-PACIFIC CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

FIGURE 19   ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 20   ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 21   ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

FIGURE 22   ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

FIGURE 23   ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

FIGURE 24   ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

FIGURE 25   ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 26   ASIA-PACIFIC INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 27   ASIA-PACIFIC INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 28   JAPAN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 29   CHINA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 30   INDIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 31   AUSTRALIA & NEW ZEALAND CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 32   SOUTH KOREA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 33   ASEAN COUNTRIES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 34   REST OF ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;